The example, I suppose, would be pharmaceuticals. With pharmaceuticals, we have a pharmacist now on strength. We have a director general of health services who is a former Canadian Armed Forces physician. We work with Medavie Blue Cross, the service provider for our treatment benefits, who have a formulary expertise as well.
Basically, we look to see what other jurisdictions in Canada are doing, and what Health Canada is doing by way of its formulary. Is this particular pharmaceutical already approved? If not, we would not approve it if it is not approved in the Canadian context. We would look out then and determine what evidence there is.